|
|
|
|
LEADER |
00000nam a2200000 i 4500 |
001 |
b12822773 |
003 |
CoU |
005 |
20221123155406.0 |
006 |
m o d f |
007 |
cr ||||||||||| |
008 |
221123s2022 dcu ob f000 0 eng c |
024 |
8 |
|
|a 46-765
|
035 |
|
|
|a (OCoLC)ocn1351607737
|
040 |
|
|
|a GPO
|b eng
|e rda
|e pn
|c GPO
|d GPO
|d MvI
|
042 |
|
|
|a pcc
|
043 |
|
|
|a n-us---
|
049 |
|
|
|a GDWR
|
074 |
|
|
|a 1043-C (online)
|
086 |
0 |
|
|a Y 4.L 11/4:S.HRG.117-185
|
086 |
0 |
|
|a Y 4.L 11/4:S.HRG.117-185
|
110 |
1 |
|
|a United States.
|b Congress.
|b Senate.
|b Committee on Health, Education, Labor, and Pensions,
|e author.
|0 http://id.loc.gov/authorities/names/no99015568.
|
245 |
1 |
3 |
|a An update from Federal officials on efforts to combat COVID-19 :
|b hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventeenth Congress, first session, on examining an update from Federal officials on efforts to combat COVID-19, May 11, 2021.
|
264 |
|
1 |
|a Washington :
|b U.S. Government Publishing Office,
|c 2022.
|
300 |
|
|
|a 1 online resource (iii, 73 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent.
|
337 |
|
|
|a computer
|b c
|2 rdamedia.
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier.
|
490 |
1 |
|
|a S. hrg. ;
|v 117-185.
|
504 |
|
|
|a Includes bibliographical references.
|
511 |
0 |
|
|a Hearing witnesses: Walensky, Rochelle, M.D., MPH, Director, United States Centers for Disease Control and Prevention, Atlanta, GA; Fauci, Anthony, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Marks, Peter, M.D., Ph.D., Director, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD; Kessler, David, M.D., Chief Science Officer, COVID Response, United States Department of Health and Human Services, Washington, DC.
|
518 |
|
|
|a Date of hearing: 2021-05-11.
|
588 |
|
|
|a Description based on online resource; title from PDF title page (GovInfo, viewed Nov. 23, 2022)
|
650 |
|
0 |
|a COVID-19 (Disease)
|z United States
|x Prevention.
|
650 |
|
0 |
|a COVID-19 (Disease)
|x Vaccination
|z United States.
|
651 |
|
0 |
|a United States
|x Officials and employees.
|0 http://id.loc.gov/authorities/subjects/sh85140391.
|
650 |
|
0 |
|a COVID-19 Pandemic, 2020-
|z United States.
|
650 |
|
7 |
|a Health.
|2 cgpa.
|
655 |
|
7 |
|a Legislative hearings.
|2 lcgft
|0 http://id.loc.gov/authorities/genreForms/gf2013025047.
|
776 |
0 |
8 |
|i Print version:
|a United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
|t Update from Federal officials on efforts to combat COVID-19
|w (OCoLC)1351605869.
|
810 |
1 |
|
|a United States.
|b Congress.
|b Senate.
|t S. hrg. ;
|v 117-185.
|0 http://id.loc.gov/authorities/names/n83707917.
|
856 |
4 |
0 |
|u https://purl.fdlp.gov/GPO/gpo189169
|7 0
|z Online Access
|
907 |
|
|
|a .b128227734
|b 03-08-23
|c 12-08-22
|
998 |
|
|
|a web
|b 12-08-22
|c -
|d m
|e -
|f eng
|g dcu
|h 3
|i 1
|
907 |
|
|
|a .b128227734
|b 12-08-22
|c 12-08-22
|
944 |
|
|
|a MARS - RDA ENRICHED
|
999 |
f |
f |
|i 5359e550-3984-5bcd-a8f8-e03ac7419c1e
|s 72da8f23-4caf-54d0-a104-d82b128ca543
|
952 |
f |
f |
|p Can circulate
|a University of Colorado Boulder
|b Online
|c Online
|d Online
|e Y 4.L 11/4:S.HRG.117-185
|h Superintendent of Documents classification
|i web
|n 1
|